E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/3/2012 in the Prospect News PIPE Daily.

Orgenesis takes in $500,000 through private placement of equity units

Deal sells 100,000 units of one share and a warrant at $1.00 per unit

By Devika Patel

Knoxville, Tenn., Aug. 3 - Orgenesis Inc. completed a $500,000 private placement of units on July 31, according to an 8-K filed Friday with the Securities and Exchange Commission.

The company sold 500,000 units of one common share and a warrant at $1.00 per unit. Each one-year warrant is exercisable at $1.00, which represents a 4.76% discount to the July 30 closing share price of $1.05.

The White Plains, N.Y., company focuses on developing a therapeutic technology that converts a patient's own liver cells into functional insulin-producing cells as a treatment for diabetes.

Issuer:Orgenesis Inc.
Issue:Units of one common share and one warrant
Amount:$500,000
Shares:500,000
Price:$1.00
Warrants:One warrant per unit
Warrant expiration:One year
Warrant strike price:$1.00
Settlement date:July 31
Stock symbol:OTCBB: ORGS
Stock price:$1.05 at close July 30
Market capitalization:$36.39 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.